However, these tumor-infiltrating CD8+ T lymphocytes exhibited a highly activated phenotype (upregulated CD25, CD44, and CD69 and down-regulated CD62L expression) but lacked effector cell function, measured by a killing assay, suggesting modulation of the CD8+ T lymphocytes by the tumor environment. This evidence concerns the gene SELL and neoplasm.